학술논문

Adjunct posterior wall isolation reduces the recurrence of atrial fibrillation in patients undergoing cryoballoon ablation: A systematic review and meta‐analysis.
Document Type
Article
Source
Journal of Cardiovascular Electrophysiology. Oct2023, Vol. 34 Issue 10, p2043-2052. 10p. 1 Diagram, 1 Chart, 2 Graphs.
Subject
*ATRIAL fibrillation prevention
*ONLINE information services
*MEDICAL databases
*ATRIAL arrhythmias
*META-analysis
*CONFIDENCE intervals
*SYSTEMATIC reviews
*RADIO frequency therapy
*ATRIAL fibrillation
*CRYOSURGERY
*CATHETER ablation
*DISEASE relapse
*COMPARATIVE studies
*DESCRIPTIVE statistics
*HEART atrium
*TACHYCARDIA
*PULMONARY veins
*MEDLINE
*ADVERSE health care events
Language
ISSN
1045-3873
Abstract
Background: Recurrence rates of atrial fibrillation (AF) remain high even after complete wide area circumferential pulmonary vein isolation (PVI). In recent years adjunct posterior wall isolation (PWI) has been performed in patients with more persistent forms of AF but the benefits remain unclear. Aim: The objective of this meta‐analysis was to evaluate the efficacy of adjunct posterior wall isolation in reducing recurrence rates of AF using cryoballoon ablation (CBA). Methods: We searched PubMed, Google Scholar, Clinicaltrials.gov and Cochrane CENTRAL. We included studies comparing PVI to PVI + PWI in patients with either persistent or paroxysmal AF (PAF) undergoing CBA. After data extraction and quality assessment of the studies, we assessed recurrence rates of atrial tachy‐arrhythmias (AF, atrial flutter, and atrial tachycardia) as well as total ablation time and procedural adverse events. Risk ratio (RR), mean difference (MD), and 95% confidence interval (CI) were calculated using Review Manager. Results: Concomitant PWI exhibited a substantial reduction in the risk of AF recurrence (RR: 0.51; 95% CI: 0.42–0.63, p <.00001), as well as all atrial arrhythmias (RR: 0.58; 95% CI: 0.49–0.68, p <.00001). On subgroup analysis, in patients with only PAF, adjunct PWI resulted in significant reduction in recurrence risk of AF (RR: 0.56; 95% CI: 0.41–0.76, p =.0002) as well. There was no significant difference in adverse events between both groups (RR: 0.90; 95% CI: 0.44–1.86; p =.78), whereas total ablation time was significantly increased in PVI + PWI group (MD: 21.75; 95% CI: 11.13–32.37, p <.0001). Conclusion: Adjunct PWI when compared to PVI alone decreases recurrence rates of atrial fibrillation after CBA of patients with persistent as well as paroxysmal atrial fibrillation. [ABSTRACT FROM AUTHOR]